1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Epigenetic Market Outlook
4.1.
Market Size &
Forecast
4.1.1.
By Value
4.2.
Market Share &
Forecast
4.2.1.
By Product & Service (Kits & Reagents, Enzymes,
Instruments & Accessories, Software, Services)
4.2.2.
By Technology (DNA Methylation, Histone Methylation, Others)
4.2.3.
By End User (Academic and Research Institutes, Pharmaceutical
Companies and Biotechnology Companies, Contract Research Organizations, Others)
4.2.4.
By Region
4.2.5.
By Company (2023)
4.3.
Market Map
4.3.1.
By Product &
Service
4.3.2.
By Technology
4.3.3.
By End user
4.3.4.
By Region
5. Asia Pacific Epigenetic Market Outlook
5.1.
Market Size &
Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Product & Service
5.2.2.
By Technology
5.2.3.
By End user
5.2.4.
By Country
5.3.
Asia Pacific:
Country Analysis
5.3.1.
China Epigenetic Market
Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Product &
Service
5.3.1.2.2.
By Technology
5.3.1.2.3.
By End user
5.3.2.
India Epigenetic Market
Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Product &
Service
5.3.2.2.2.
By Technology
5.3.2.2.3.
By End user
5.3.3.
Australia Epigenetic
Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Product &
Service
5.3.3.2.2.
By Technology
5.3.3.2.3.
By End user
5.3.4.
Japan Epigenetic Market
Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Product &
Service
5.3.4.2.2.
By Technology
5.3.4.2.3.
By End user
5.3.5.
South Korea Epigenetic
Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Product &
Service
5.3.5.2.2.
By Technology
5.3.5.2.3.
By End user
6. Europe Epigenetic Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1. By Product &
Service
6.2.2.
By Technology
6.2.3.
By End user
6.2.4.
By Country
6.3.
Europe: Country
Analysis
6.3.1.
France Epigenetic Market
Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product &
Service
6.3.1.2.2.
By Technology
6.3.1.2.3.
By End user
6.3.2.
Germany Epigenetic Market
Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product &
Service
6.3.2.2.2.
By Technology
6.3.2.2.3.
By End user
6.3.3.
Spain Epigenetic Market
Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product &
Service
6.3.3.2.2.
By Technology
6.3.3.2.3.
By End user
6.3.4.
Italy Epigenetic Market
Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Product &
Service
6.3.4.2.2.
By Technology
6.3.4.2.3.
By End user
6.3.5.
United Kingdom Epigenetic
Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Product &
Service
6.3.5.2.2.
By Technology
6.3.5.2.3.
By End user
7. North America Epigenetic Market Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share &
Forecast
7.2.1. By Product &
Service
7.2.2.
By Technology
7.2.3.
By End user
7.2.4.
By Country
7.3.
North America:
Country Analysis
7.3.1.
United States Epigenetic
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product &
Service
7.3.1.2.2.
By Technology
7.3.1.2.3.
By End user
7.3.2.
Mexico Epigenetic Market
Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product &
Service
7.3.2.2.2.
By Technology
7.3.2.2.3.
By End user
7.3.3.
Canada Epigenetic Market
Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product &
Service
7.3.3.2.2.
By Technology
7.3.3.2.3.
By End user
8. South America Epigenetic Market Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1. By Product &
Service
8.2.2.
By Technology
8.2.3.
By End user
8.2.4.
By Country
8.3.
South America:
Country Analysis
8.3.1.
Brazil Epigenetic Market
Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product &
Service
8.3.1.2.2.
By Technology
8.3.1.2.3.
By End user
8.3.2.
Argentina Epigenetic
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product & Service
8.3.2.2.2.
By Technology
8.3.2.2.3.
By End user
8.3.3.
Colombia Epigenetic Market
Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product &
Service
8.3.3.2.2.
By Technology
8.3.3.2.3.
By End user
9. Middle East and Africa Epigenetic Market Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1. By Product &
Service
9.2.2.
By Technology
9.2.3.
By End user
9.2.4.
By Country
9.3.
MEA: Country
Analysis
9.3.1.
South Africa Epigenetic
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product & Service
9.3.1.2.2.
By Technology
9.3.1.2.3.
By End user
9.3.2.
Saudi Arabia Epigenetic
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product &
Service
9.3.2.2.2.
By Technology
9.3.2.2.3.
By End user
9.3.3.
UAE Epigenetic Market
Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product &
Service
9.3.3.2.2.
By Technology
9.3.3.2.3.
By End user
10.
Market Dynamics
10.1.
Drivers
10.2.
Challenges
11.
Market Trends & Developments
11.1.
Recent Developments
11.2.
Product Launches
11.3.
Mergers &
Acquisitions
12.
Global Epigenetic
Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Product
14.
Competitive
Landscape
14.1. Abcam Limited
14.1.1. Business Overview
14.1.2.
Company Snapshot
14.1.3.
Product &
Services
14.1.4.
Financials (In case
of listed)
14.1.5.
Recent Developments
14.1.6.
SWOT Analysis
14.2.
Active Motif Inc
14.3.
Hologic, Inc.
14.4.
F Hoffmann-La Roche
Ltd.
14.5.
Illumina, Inc.
14.6.
Qiagen N.V.
14.7.
Thermo Fisher
Scientific Inc
14.8.
Novartis AG
14.9.
Element Biosciences
14.10.Dovetail
Genomics LLC
15.
Strategic Recommendations
16.
About Us & Disclaimer